---
schema_version: "secwatch.filing_event.v1"
accession: "0001636422-23-000041"
form_type: "8-K"
ticker: "HCAT"
cik: "0001636422"
company_name: "Health Catalyst, Inc."
filed_at: "2023-03-30T23:59:59+00:00"
generated_at: "2026-06-17T09:15:55.401767+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Health Catalyst appoints COO/CPO and new General Counsel; GC Orenstein to step down

## Summary
- Anne Marie Bickmore, current CPO, becomes COO and CPO effective April 3, 2023.
- Daniel Orenstein resigns as General Counsel and Corporate Secretary effective April 30, 2023, to pursue other opportunities.
- Benjamin Landry, Assistant General Counsel, promoted to General Counsel and Corporate Secretary effective May 1, 2023.
- Orenstein to remain as Senior Advisor under independent contractor agreement for transition.
- No disagreement or conflict cited for Orenstein's departure.

## SEC filing metadata
- accession: 0001636422-23-000041
- form_type: 8-K
- ticker: HCAT
- cik: 0001636422
- company_name: Health Catalyst, Inc.
- filed_at: 2023-03-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1636422/000163642223000041/0001636422-23-000041-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1636422/000163642223000041/hcat-20230324.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001636422-23-000041
- JSON: https://secwatch.observer/filing/0001636422-23-000041.json
- Plain text: https://secwatch.observer/filing/0001636422-23-000041.txt

## Key facts
- Executive change
  Anne Marie Bickmore was appointed as Chief Operating Officer and Chief Product Officer at Health Catalyst, Inc..
  - Action: appointed
  - Role: Chief Operating Officer and Chief Product Officer
  source text: On March 30, 2023, Health Catalyst, Inc. (the “ Company ”) announced that Anne Marie Bickmore, age 60, the Company’s Chief Product Officer, will assume the role of Chief Operating Officer and Chief Product Officer of the Company, effective April 3, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1636422/000163642223000041/0001636422-23-000041-index.htm
- Executive change
  Daniel Orenstein resigned as General Counsel and Corporate Secretary at Health Catalyst, Inc..
  - Action: resigned
  - Role: General Counsel and Corporate Secretary
  source text: On March 24, 2022, Daniel Orenstein provided notice to the Company that, effective April 30, 2023, Mr. Orenstein will step down from his position as General Counsel and Corporate Secretary of the Company to pursue other opportunities.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1636422/000163642223000041/0001636422-23-000041-index.htm
- Executive change
  Benjamin Landry was appointed as General Counsel and Corporate Secretary at Health Catalyst, Inc..
  - Action: appointed
  - Role: General Counsel and Corporate Secretary
  source text: On March 30, 2023, the Company announced that Benjamin Landry, age 41, the Company’s Assistant General Counsel, will assume the role of General Counsel and Corporate Secretary of the Company, effective May 1, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1636422/000163642223000041/0001636422-23-000041-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.